Literature DB >> 16845242

First case of Penicillium marneffei fungemia in Greece and strain susceptibility to five licensed systemic antifungal agents and posaconazole.

Anna Filiotou1, Aristea Velegraki, Markos Giannaris, Maria Pirounaki, Ageliki Mitroussia, Andreas Kaloterakis, Athanassios Archimandritis.   

Abstract

We report the first case of Penicillium marneffei infection in a Greek bisexual man who is a frequent traveler to China. Penicilliosis and AIDS were diagnosed and antifungal treatment plus highly active antiretroviral therapy were administered successfully. In nonendemic areas travel history, clinical suspicion and laboratory alertness are critical for infection management.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16845242     DOI: 10.1097/00000441-200607000-00009

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  5 in total

1.  Acute Disseminated Talaromyces marneffei in An Immunocompetent Patient.

Authors:  Pingli Wang; Youfei Chen; Hao Xu; Liren Ding; Zuqun Wu; Zhijiang Xu; Kai Wang
Journal:  Mycopathologia       Date:  2017-03-27       Impact factor: 2.574

2.  In Vitro Activity of Posaconazole against Talaromyces marneffei by Broth Microdilution and Etest Methods and Comparison to Itraconazole, Voriconazole, and Anidulafungin.

Authors:  Susanna K P Lau; George C S Lo; Clare S K Lam; Wang-Ngai Chow; Antonio H Y Ngan; Alan K L Wu; Dominic N C Tsang; Cindy W S Tse; Tak-Lun Que; Bone S F Tang; Patrick C Y Woo
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

Review 3.  Bloodstream infections in HIV-infected patients.

Authors:  Lucia Taramasso; Paola Tatarelli; Antonio Di Biagio
Journal:  Virulence       Date:  2016-04-02       Impact factor: 5.882

4.  Fungemia caused by Penicillium marneffei in an immunocompetent patient with COPD: A unique case report.

Authors:  Xiaoming Yu; Xueding Cai; Xiaomei Xu; Lin Zhang; Xiaoying Huang; Liangxing Wang; Yanfan Chen
Journal:  Medicine (Baltimore)       Date:  2018-01       Impact factor: 1.889

5.  MALDI-TOF MS-Based Clustering and Antifungal Susceptibility Tests of Talaromyces marneffei Isolates from Fujian and Guangxi (China).

Authors:  Lili Fang; Minxue Liu; Chunlan Huang; Jian Guo; Xiaobo Ma; Yanqing Zheng; Wenjuan Wu; Jiangshan Huang; Heping Xu
Journal:  Infect Drug Resist       Date:  2022-07-01       Impact factor: 4.177

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.